Teaming up to improve breast cancer treatments through a new approach
Treating without surgery: the ultimate goal that radiation oncologists at the MUHC and HMR hope to achieve
Immunotherapy before surgery shows promise for esophageal cancer
New study by researchers at The Institute finds improved survival and potential for personalized treatment
First patient in Canada receives mRNA-based bladder cancer treatment in clinical trial at the MUHC
The investigational therapy combines mRNA technology with immunotherapy...
D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer
Three members of The Institute are among recipients of D2R funding to support their groundbreaking...
Inaugural Research Canada Innovates event at The Institute a resounding success
Sold-out event united health researchers and innovators to shape the future of healthcare
Celebrating International Women’s Day at The Institute
EACARE hosts an inspiring event, fostering mentorship, career development, and gender equity in science and research
Final winners announced in inaugural Networks competition
Three interdisciplinary teams awarded funding to launch innovative research networks at The Institute
New review article by trainee from The Institute
Doctoral candidate Yunxi Chen explores the translation of extracellular vesicles into nanomedicine through the engineering of synthetic systems
Advancing Equity in Research
For Black History Month, patient partners, community actors, academics, and clinicians gathered at The Institute to address racism
D2R awards over $6 million to support Core Platforms
Three platforms at The Institute will benefit from new funding for innovation and sustainability